Study of Ruxolitinib in Colorectal Cancer Patients

Investigator: Eric Bernicker, MD

Study Coordinator: Lacey Burey

Status: Enrolling Number: NCT02119676

Phone: 713.441.1159

IRB Number: Pro00011139


The purpose of this study is to determine if ruxolitinib, in combination with regorafenib, is safe and effective in the treatment of metastatic colorectal cancer.
More to Explore